Skip to Content
Print Share

Medications for Renal Cell Carcinoma

Drugs associated with Renal Cell Carcinoma

The following drugs and medications are in some way related to, or used in the treatment of this condition.

What is Renal Cell Carcinoma: Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type of kidney cancer in adults

See also: sub-topics

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Cabometyx Rx D N Add review Add

Generic name: cabozantinib systemic

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
cabozantinib Rx D N Add review Add

Generic name: cabozantinib systemic

Brand name:  Cabometyx

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
capecitabine Off Label Rx D N Add review Add

Generic name: capecitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Depo-Provera Rx X N Add review Add

Generic name: medroxyprogesterone systemic

Drug class: hormones/antineoplastics, contraceptives, progestins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Depo-Provera Contraceptive Rx X N Add review Add

Generic name: medroxyprogesterone systemic

Drug class: hormones/antineoplastics, contraceptives, progestins

For consumers: dosage, interactions, side effects

 
depo-subQ provera 104 Rx X N Add review Add

Generic name: medroxyprogesterone systemic

Drug class: hormones/antineoplastics, contraceptives, progestins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
erlotinib Off Label Rx D N Add review Add

Generic name: erlotinib systemic

Brand name:  Tarceva

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Off Label: Yes

 
lenvatinib Rx N Add review Add

Generic name: lenvatinib systemic

Brand name:  Lenvima

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Lenvima Rx N Add review Add

Generic name: lenvatinib systemic

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
nivolumab Rx N Add review Add

Generic name: nivolumab systemic

Brand name:  Opdivo

Drug class: Anti-PD-1 monoclonal antibodies

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Opdivo Rx N Add review Add

Generic name: nivolumab systemic

Drug class: Anti-PD-1 monoclonal antibodies

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
peginterferon alfa-2b Rx C N Add review Add

Generic name: peginterferon alfa-2b systemic

Brand name:  PegIntron

Drug class: antineoplastic interferons, antiviral interferons

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

 
PegIntron Rx C N Add review Add

Generic name: peginterferon alfa-2b systemic

Drug class: antineoplastic interferons, antiviral interferons

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Tarceva Off Label Rx D N Add review Add

Generic name: erlotinib systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
axitinib Rx D N Add review
6.0

Generic name: axitinib systemic

Brand name:  Inlyta

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Inlyta Rx D N Add review
6.0

Generic name: axitinib systemic

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Afinitor Rx D N 1 review
7.0

Generic name: everolimus systemic

Drug class: mTOR inhibitors, selective immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
everolimus Rx D N 1 review
7.0

Generic name: everolimus systemic

Brand name:  Afinitor

Drug class: mTOR inhibitors, selective immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
medroxyprogesterone Rx X N 1 review
7.0

Generic name: medroxyprogesterone systemic

Brand names:  Depo-Provera, Provera, Depo-Provera Contraceptive, depo-subQ provera 104 …

Drug class: hormones/antineoplastics, contraceptives, progestins

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Provera Rx X N 1 review
7.0

Generic name: medroxyprogesterone systemic

Drug class: hormones/antineoplastics, contraceptives, progestins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
sunitinib Rx D N 17 reviews
7.0

Generic name: sunitinib systemic

Brand name:  Sutent

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Sutent Rx D N 16 reviews
7.0

Generic name: sunitinib systemic

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Avastin Rx C N 1 review
8.0

Generic name: bevacizumab systemic

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
bevacizumab Rx C N 1 review
8.0

Generic name: bevacizumab systemic

Brand name:  Avastin

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
pazopanib Rx D N 24 reviews
8.0

Generic name: pazopanib systemic

Brand name:  Votrient

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Page 1 2 Next

Topics under Renal Cell Carcinoma

Learn more about Renal Cell Carcinoma

Micromedex® Care Notes:

Symptoms and treatment for:

Mayo Clinic Reference:

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N The drug is not subject to the Controlled Substances Act.
1 The drug has a high potential for abuse. The drug has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug under medical supervision.
2 The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
3 The drug has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
4 The drug has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
5 The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
Alcohol
X Interacts with Alcohol.

Synonym(s): Adenocarcinoma of renal cells; Cancer, Hypernephroma; Cancer, Kidney; Cancer, Renal; Cancer, Renal Cell Carcinoma; Hypernephroma; Kidney Cancer; Renal Cancer

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Drugs.com Mobile Apps

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Explore Apps
Hide